MEDINET Co., Ltd. (2370.T)
JPY 31.0
(0.0%)
JPY 31.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 661.54 Million JPY | 4.4% |
| 2022 | 633.67 Million JPY | -7.23% |
| 2021 | 683.03 Million JPY | -12.77% |
| 2020 | 783.03 Million JPY | -26.06% |
| 2019 | 1.05 Billion JPY | 6.08% |
| 2018 | 998.27 Million JPY | -41.42% |
| 2017 | 1.7 Billion JPY | -10.75% |
| 2016 | 1.9 Billion JPY | 14.03% |
| 2015 | 1.67 Billion JPY | -9.2% |
| 2014 | 1.84 Billion JPY | -12.63% |
| 2013 | 2.11 Billion JPY | -3.68% |
| 2012 | 2.19 Billion JPY | -18.07% |
| 2011 | 2.67 Billion JPY | -16.5% |
| 2010 | 3.2 Billion JPY | 10.42% |
| 2009 | 2.9 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 189.79 Million JPY | 25.31% |
| 2024 Q2 | 151.45 Million JPY | -38.99% |
| 2024 Q1 | 248.23 Million JPY | 46.35% |
| 2023 Q4 | 169.62 Million JPY | 19.02% |
| 2023 FY | 661.54 Million JPY | 4.4% |
| 2023 Q2 | 164.26 Million JPY | -11.28% |
| 2023 Q3 | 142.5 Million JPY | -13.24% |
| 2023 Q1 | 185.15 Million JPY | 12.98% |
| 2022 FY | 633.67 Million JPY | -7.23% |
| 2022 Q4 | 163.88 Million JPY | 8.04% |
| 2022 Q2 | 145.23 Million JPY | -15.98% |
| 2022 Q1 | 172.85 Million JPY | 1.22% |
| 2022 Q3 | 151.69 Million JPY | 4.45% |
| 2021 Q3 | 237.4 Million JPY | 75.96% |
| 2021 Q1 | 139.93 Million JPY | -3.83% |
| 2021 Q2 | 134.92 Million JPY | -3.58% |
| 2021 Q4 | 170.77 Million JPY | -28.06% |
| 2021 FY | 683.03 Million JPY | -12.77% |
| 2020 FY | 783.03 Million JPY | -26.06% |
| 2020 Q4 | 145.5 Million JPY | 10.85% |
| 2020 Q1 | 295.55 Million JPY | -2.7% |
| 2020 Q2 | 210.71 Million JPY | -28.71% |
| 2020 Q3 | 131.26 Million JPY | -37.71% |
| 2019 Q1 | 248.69 Million JPY | 8.96% |
| 2019 Q3 | 253.59 Million JPY | 0.25% |
| 2019 Q4 | 303.76 Million JPY | 19.78% |
| 2019 FY | 1.05 Billion JPY | 6.08% |
| 2019 Q2 | 252.96 Million JPY | 1.72% |
| 2018 Q2 | 247.63 Million JPY | -16.06% |
| 2018 Q3 | 227.37 Million JPY | -8.18% |
| 2018 FY | 998.27 Million JPY | -41.42% |
| 2018 Q1 | 295.01 Million JPY | -24.17% |
| 2018 Q4 | 228.25 Million JPY | 0.38% |
| 2017 Q1 | 451.31 Million JPY | -10.69% |
| 2017 FY | 1.7 Billion JPY | -10.75% |
| 2017 Q2 | 442.48 Million JPY | -1.96% |
| 2017 Q4 | 389.04 Million JPY | -7.63% |
| 2017 Q3 | 421.17 Million JPY | -4.82% |
| 2016 Q4 | 505.32 Million JPY | 5.93% |
| 2016 Q1 | 465.34 Million JPY | 10.52% |
| 2016 Q2 | 461.6 Million JPY | -0.8% |
| 2016 Q3 | 477.04 Million JPY | 3.34% |
| 2016 FY | 1.9 Billion JPY | 14.03% |
| 2015 FY | 1.67 Billion JPY | -9.2% |
| 2015 Q2 | 454.74 Million JPY | 11.27% |
| 2015 Q4 | 421.04 Million JPY | 7.98% |
| 2015 Q3 | 389.91 Million JPY | -14.26% |
| 2015 Q1 | 408.67 Million JPY | -4.13% |
| 2014 Q2 | 471.73 Million JPY | -10.45% |
| 2014 FY | 1.84 Billion JPY | -12.63% |
| 2014 Q4 | 426.26 Million JPY | 1.68% |
| 2014 Q3 | 419.23 Million JPY | -11.13% |
| 2014 Q1 | 526.76 Million JPY | -4.01% |
| 2013 Q2 | 508.32 Million JPY | -1.68% |
| 2013 Q3 | 536.33 Million JPY | 5.51% |
| 2013 Q4 | 548.76 Million JPY | 2.32% |
| 2013 FY | 2.11 Billion JPY | -3.68% |
| 2013 Q1 | 517.02 Million JPY | -3.17% |
| 2012 Q3 | 542.37 Million JPY | -5.1% |
| 2012 Q1 | 543.11 Million JPY | -12.94% |
| 2012 FY | 2.19 Billion JPY | -18.07% |
| 2012 Q2 | 571.52 Million JPY | 5.23% |
| 2012 Q4 | 533.97 Million JPY | -1.55% |
| 2011 FY | 2.67 Billion JPY | -16.5% |
| 2011 Q3 | 607.95 Million JPY | -13.43% |
| 2011 Q2 | 702.24 Million JPY | -5.12% |
| 2011 Q4 | 623.87 Million JPY | 2.62% |
| 2011 Q1 | 740.11 Million JPY | -10.7% |
| 2010 Q3 | 783.76 Million JPY | -1.88% |
| 2010 Q1 | 791.11 Million JPY | -11.83% |
| 2010 FY | 3.2 Billion JPY | 10.42% |
| 2010 Q4 | 828.79 Million JPY | 5.74% |
| 2010 Q2 | 798.81 Million JPY | 0.97% |
| 2009 Q4 | 897.22 Million JPY | 11.35% |
| 2009 Q2 | 598.61 Million JPY | 0.0% |
| 2009 FY | 2.9 Billion JPY | 0.0% |
| 2009 Q1 | 598.59 Million JPY | 0.0% |
| 2009 Q3 | 805.77 Million JPY | 34.61% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 86.131% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -485.82% |
| GNI Group Ltd. | 26.01 Billion JPY | 97.457% |
| Linical Co., Ltd. | 12.3 Billion JPY | 94.625% |
| Trans Genic Inc. | 13.08 Billion JPY | 94.944% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 87.176% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 57.604% |
| AnGes, Inc. | 152.98 Million JPY | -332.423% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -8.429% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 94.818% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 18.998% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -388.195% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 59.312% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -54.435% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 65.204% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 3.066% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 72.79% |
| PeptiDream Inc. | 28.71 Billion JPY | 97.696% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -949.435% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -446.73% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -918709.722% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -1558.543% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 85.333% |
| FunPep Company Limited | 530 Thousand JPY | -124719.434% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -855.297% |
| Stella Pharma Corporation | 269.49 Million JPY | -145.479% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -108.809% |
| Cuorips Inc. | 23.1 Million JPY | -2763.575% |
| K Pharma,Inc. | 1 Billion JPY | 33.846% |
| Takara Bio Inc. | 43.5 Billion JPY | 98.479% |
| ReproCELL Incorporated | 2.42 Billion JPY | 72.74% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 61.433% |
| StemCell Institute Inc. | 2.48 Billion JPY | 73.338% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 73.688% |
| CellSeed Inc. | 190.13 Million JPY | -247.935% |